Vaccine Treatment for Hormone Refractory Prostate Cancer

Clinical trial NCT00105053 · COMPLETED

Trial details

NCT number: NCT00105053
Sponsor: NewLink Genetics Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2005-03-01
Primary completion: 2007-09-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.